2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
80
Thoracic
13
Breast
9
Gynecologic
8
NET
6
Endocrine
6
Head & Neck
5
Genitourinary
5
Dermatologic
5
Classical hematology
3
Sarcoma
2
Lymphoid
2
CNS
2
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
3503
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2496
Leukemia
2360
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Myelodysplastic Syndromes
1411
Hematologic Neoplasms
1382
Lymphoma
1175
Lymphoma, Non-Hodgkin
1079
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
863
Lymphoma, Follicular
761
Multiple Myeloma
739
Lymphoma, Mantle-Cell
730
Lymphoma, Large B-Cell, Diffuse
714
Burkitt Lymphoma
691
Lymphoma, B-Cell, Marginal Zone
645
Hodgkin Disease
636
Recurrence
627
Leukemia, Myelomonocytic, Chronic
536
Neoplasms
516
Lymphoma, Large-Cell, Immunoblastic
451
Myeloproliferative Disorders
445
Leukemia, Myeloid, Chronic-Phase
437
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
414
Congenital Abnormalities
411
Waldenstrom Macroglobulinemia
360
Blast Crisis
353
Leukemia, Myeloid, Accelerated Phase
318
Lymphoma, T-Cell, Cutaneous
311
Primary Myelofibrosis
297
Neoplasms, Plasma Cell
276
Interventions
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Intestinal Neoplasms
×
Other hematologic neoplasm
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled